Radiomics in ¹⁸F-FDG PET/CT predicts HER2 status in breast cancer with equivocal immunohistochemistry

Eur J Radiol. 2024 Jan:170:111238. doi: 10.1016/j.ejrad.2023.111238. Epub 2023 Nov 28.

Author

Caroline Malhaire¹

Affiliation

¹ Institut Curie, Department of Medical Imaging, PSL Research University, 26 rue d'Ulm, 75005 Paris, France; Institut Curie, Research Center, U1288-LITO, Inserm, Paris-Saclay University, 91401 Orsay, France. Electronic address: caroline.malhaire@curie.fr.

PMID: 38043379
DOI: 10.1016/j.ejrad.2023.111238

No abstract available

Publication types

Editorial

MeSH terms

Breast Neoplasms* / diagnostic imaging
Female
Fluorodeoxyglucose F18
Humans
Immunohistochemistry
Positron Emission Tomography Computed Tomography
Radiomics

Substances

Fluorodeoxyglucose F18